ArticleJournal of the Medical Library Association : JMLA2026
Pharmacist resource use across the United States: implications for teaching and practice.
Article in Journal of the Medical Library Association : JMLA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To analyze practicing pharmacists' use of drug information (DI) resources in the United States. Methods: An electronic survey was distributed to practicing US pharmacists through professional organization email lists and social media. The survey questionnaire asked respondents which subscription-based DI resources are provided through their employer, whether they personally pay for additional resources, how often they use subscription-based resources, and other related questions. Results: The survey received 430 responses, 387 of which were able to be fully analyzed. The resources that respondents most frequently had access to through their employer were UpToDate (77.0%), Lexicomp (74.9%), and Micromedex (62.3%). Many respondents (40.8%) paid for subscriptions with personal funds, and 28.9% reported never experiencing access issues due to payment barriers. Respondents in community settings were more likely to have paid for resources with personal funds (57.1%, p<0.05) and have less access to resources (51.4%, p<0.05). In the open-text responses, the most desired resources were point-of-care tools (UpToDate) and DI databases (Lexicomp). Conclusions: US pharmacists experience a varied level of access to DI resources through their employer. Pharmacy educators should focus their instruction on resources that are the most accessible to practicing pharmacists. Many, especially community pharmacists, pay out of pocket for desired resources, presenting an opportunity to advocate for increased resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.